| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 335.53B | 322.56B | 303.03B | 279.31B | 245.42B | 266.75B |
| Gross Profit | 108.36B | 109.81B | 101.96B | 90.20B | 83.95B | 117.81B |
| EBITDA | 40.90B | 44.05B | 43.18B | 34.83B | 37.85B | 37.29B |
| Net Income | 16.14B | 20.87B | 19.89B | 14.77B | 18.05B | 17.68B |
Balance Sheet | ||||||
| Total Assets | 328.17B | 319.17B | 292.16B | 239.09B | 236.60B | 238.98B |
| Cash, Cash Equivalents and Short-Term Investments | 34.90B | 56.76B | 44.30B | 32.17B | 59.00B | 73.47B |
| Total Debt | 52.09B | 36.55B | 27.04B | 1.85B | 1.98B | 6.56B |
| Total Liabilities | 111.59B | 104.10B | 91.07B | 56.41B | 53.14B | 56.24B |
| Stockholders Equity | 205.34B | 205.18B | 191.75B | 174.11B | 175.38B | 175.37B |
Cash Flow | ||||||
| Free Cash Flow | 10.87B | 10.99B | -6.84B | -7.41B | 8.81B | 19.11B |
| Operating Cash Flow | 30.89B | 39.10B | 24.35B | 19.31B | 22.33B | 30.45B |
| Investing Cash Flow | -18.70B | -28.60B | -35.31B | -20.33B | 3.64B | -32.07B |
| Financing Cash Flow | -10.53B | 2.54B | 16.85B | -20.00B | -25.17B | -7.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥91.61B | 3.42 | ― | 1.47% | 20.44% | 1199.18% | |
73 Outperform | ¥710.86B | 16.97 | 9.18% | 1.13% | 3.53% | 4.88% | |
66 Neutral | ¥398.86B | 23.84 | 8.27% | 1.95% | 5.82% | -13.40% | |
65 Neutral | ¥393.51B | 76.68 | 2.66% | 1.64% | 8.40% | -23.50% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥1.11T | 23.73 | 5.97% | 2.96% | 2.79% | -6.46% | |
61 Neutral | ¥49.93B | 21.24 | ― | 1.19% | 3.71% | -4.44% |